CVS Health Executive Joins Atman Health Advisory Board
Dr. David Fairchild of CVS Health has been appointed to the Strategic Advisory Board of Atman Health to support the development of autonomous cardiovascular care.
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Dr. David Fairchild of CVS Health has been appointed to the Strategic Advisory Board of Atman Health to support the development of autonomous cardiovascular care.
Argus Research has revised its price target for CVS Health Corporation, lowering it from $114 to $105.
At least 11 states offer extra ACA premium help in 2027 after subsidies lapsed.
U.S. Senators have launched an inquiry into Molina Healthcare and other major insurers regarding their cooperation with the Trump administration in terminating Affordable Care Act (ACA) coverage for 760,000 enrollees.
U.S. Senators have sent a letter to Centene and other major insurers demanding information regarding their cooperation with the administration in terminating health coverage for 760,000 enrollees.
A group of Senate Democrats has initiated an inquiry into ten major health insurance companies, including UnitedHealthcare, regarding their collaboration with the Trump administration on Affordable Care Act coverage terminations.